Fischer Medical Ventures Ltd (FISCHER) is currently trading at 33.54 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Fischer Medical Ventures Limited specializes in developing advanced, affordable MRI systems, located in the Andhra Pradesh MedTech Zone. It has a significant international footprint and is focused on enhancing medical imaging accessibility worldwide. The company saw a remarkable growth in revenue, increasing by 118% year-on-year to INR 86 crores for Q2 FY26, and maintains a strong EBITDA margin of 21%. The core focus is on Radiology and Preventive Healthcare, leveraging Make-In-India and PLI schemes for medical devices to strengthen its market position. Fischer Medical has successfully integrated AI in diagnostic imaging, enhancing its capabilities in telemedicine and preventative health through innovations in MRI technology. It is expanding its presence in international markets such as MENA, Southeast Asia, and Africa, reflecting growing export opportunities and a shift in revenue focus beyond India.

Over the past 52 weeks, Fischer Medical Ventures Ltd has traded between a low of ₹31.00 and a high of ₹121.45. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Fischer Medical Ventures Ltd has a market capitalization of approximately 2,340.60. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Fischer Medical Ventures Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 95.71 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 2,340.60 Cr, Fischer Medical Ventures Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Fischer Medical Ventures Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Fischer Medical Ventures Ltd is 95.71. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Shankar Varadharajan and PACs increased their aggregate shareholding to 62.66% of the total voting capital after the August 12, 2026 transaction.

The plan to establish five regional Medical Value Tourism Hubs and increase trauma care capacity in district hospitals are the most significant, as they create direct, large-scale demand for the company's MRI and CT systems.